Although approximately 50 percent of cancer patients in developing countries need radiation therapy (RT), up to half of these patients do not have access to it, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. The findings were presented at the American Society for Radiation Oncology (ASTRO) meeting, Sept. 25-28 in Boston.

If we are to look forward to the development of smartphone technology for radiology applications, we might do well to look at virtual and augmented realities. For decades, radiology has fiddled with these.

Samsung announced recently that The University of Texas MD Anderson Cancer Center in Houston added BodyTom CT, the world’s first portable, full-body, 32-slice computed tomography (CT) scanner to its Proton Therapy Center. The center is now treating patients using images from the scanner as part of the process.

September 28, 2016 – Addressing the educational needs of an underserved and growing population, DenseBreast-info.org now provides two key Patient resource tools in Spanish, a Breast Cancer Risk Checklist and a Patient Brochure. The website addresses questions women and their healthcare providers often have about breast density – helping them to "Get Smart about Being Dense."

Survival rates for elderly patients receiving stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

September 27, 2016 — For men with early stage, low-risk prostate cancer, hypofractionated radiation therapy (RT) offers comparable health-related quality of life outcomes in one-third less treatment time than conventional RT, according to new research. The research was presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

September 27, 2016 — Carestream Health announced that it will be displaying a wide range of products at the 2016 Annual Meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 2 in Chicago. Featured products will include:

OnSight 3-D Extremity System

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT). These findings were drawn from research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston.

Elekta announced that it has expanded its partnership with Radiating Hope, a volunteer organization that provides radiation equipment to resource-constrained countries. The organization also educates medical physics and radiation oncology personnel in those countries to help better serve their patient populations.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now